Treatment of peripheral T cell lymphoma
US11999784B2 · kind B2 · utility
0Cited by
1References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 25, 2019 |
| Grant date | Jun 4, 2024 |
| Priority date | — |
| Expiry date | Oct 30, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70503
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present disclosure relates to methods for the treatment, prevention and diagnosis of peripheral T-cell lymphoma using compounds that specifically bind NKp46. Included in particular are compounds that bind NKp46 and deplete tumor cells that express NKp46 at their surface, and pharmaceutical compositions comprising the same. The disclosure also relates to the use of antibodies that specifically bind NKp46 in diagnostic and theranostic assays in the detection and treatment of peripheral T-cell lymphoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.